Monrovia, California
United States
76
2024-01-25
The entities that hold a legal rights for patent applications filed by inventor Vafa Omid:
Omid Vafa from Monrovia, US has applied for patents for these inventions. The list has both pending applications and granted patents:
OPTIMIZED Fc VARIANTS
#2 | 2021-05-13Optimized Fc variants
#3 | 2019-03-07Fc variants with increased affinity for FcγRIIc
#4 | 2018-12-20NOVEL IMMUNOGLOBULIN VARIANTS
#5 | 2018-07-26OPTIMIZED Fc VARIANTS
#6 | 2018-05-24OPTIMIZED FC VARIANTS AND METHODS FOR THEIR GENERATION
#7 | 2017-06-15NOVEL IMMUNOGLOBULIN VARIANTS
#8 | 2016-12-01OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION
#9 | 2016-12-01Optimized Fc variants and methods for their generation
#10 | 2016-11-24OPTIMIZED FC VARIANTS
#11 | 2016-11-03Optimized Fc variants and methods for their generation
#12 | 2016-10-20Optimized Fc variants
#13 | 2015-11-05OPTIMIZED Fc VARIANTS
#14 | 2015-08-20Fc variants with increased affinity for FcyRIIc
#15 | 2015-03-19Optimized Fc variants and methods for their generation
#16 | 2015-03-12NOVEL IMMUNOGLOBULIN VARIANTS
#17 | 2015-01-29OPTIMIZED Fc VARIANTS
#18 | 2015-01-29OPTIMIZED Fc VARIANTS
#19 | 2015-01-08OPTIMIZED Fc VARIANTS
#20 | 2015-01-08Optimized Fc variants
#21 | 2014-12-25Optimized Fc variants and methods for their generation
#22 | 2014-12-18OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION
#23 | 2014-03-13Optimized Fc variants
#24 | 2013-11-14Optimized Fc variants
#25 | 2013-10-17Optimized Fc variants
#26 | 2013-10-03Optimized Fc Variants
#27 | 2013-09-19Optimized Fc variants and methods for their generation
#28 | 2013-08-15Optimized Fc variants
#29 | 2013-08-15Optimized Fc Variants
#30 | 2013-08-08Immunoglobulins insertions, deletions, and substitutions
#31 | 2013-06-20Optimized Fc variants and methods for their generation
#32 | 2013-06-20Optimized FC variants and methods for their generation
#33 | 2013-03-07Optimized fc variants and methods for their generation
#34 | 2012-10-11Optimized Fc Variants
#35 | 2012-09-13Optimized Fc variants and methods for their generation
#36 | 2012-09-06Immunoglobulin insertions, deletions, and substitutions
#37 | 2011-01-27Optimized Fc Variants
#38 | 2010-12-16IgG Immunoglobulin Variants with Optimized Effector Function
#39 | 2009-08-27Optimized Fc Variants and methods for their generation
#40 | 2009-08-27Optimized Fc Variants and Methods for Their Generation
#41 | 2009-06-04Optimized Fc Variants and Methods for Their Generation
#42 | 2009-04-09Optimized Fc variants and methods for their generation
#43 | 2009-03-26Optimized Fc variants and methods for their generation
#44 | 2009-03-12Optimized Fc variants and methods for their generation
#45 | 2009-03-12Optimized Fc variants and methods for their generation
#46 | 2009-02-26Immunoglobulin insertions, deletions and substitutions
#47 | 2009-02-26Optimized Fc variants
#48 | 2009-01-08Fc Variants Having Decreased Affinity for FcyRIIb
#49 | 2008-11-27Optimized Fc Variants and Methods for Their Generation
#50 | 2008-07-31Optimized Fc Variants and Methods for Their Generation
#51 | 2008-07-03Fc Variants with Increased Affinity for FcyRIIc
#52 | 2008-06-26Fc variants with increased affinity for FcγRIIc
#53 | 2008-03-06Fc Variants with Increased Affinity for FcyRIIC
#54 | 2008-02-28Fc Variants with Increased Affinity for FcyRIIc
#55 | 2007-12-13Fc Variants Having Decreased Affinity for FcyRl
#56 | 2007-10-25Fc Variants with Increased Affinity for FcyRlla
#57 | 2007-10-25Fc variants having increased affinity for fcyrllc
#58 | 2007-10-18Fc Variants Having Decreased Affinity for FcyRlla
#59 | 2007-10-11Fc Variants Having Decreased Affinity for FcyRIIc
#60 | 2007-10-11Fc Variants Having Decreased Affinity for FcyRllla
#61 | 2007-10-11Fc Variants Having Increased Affinity for FcyRllla
#62 | 2007-10-11Fc Variants Having Increased Affinity for FcyRl
#63 | 2007-10-04Fc variants
#64 | 2007-09-27OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION
#65 | 2007-09-27CD20 OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION
#66 | 2007-09-20CD52 OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION
#67 | 2007-08-30Her2/neu OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION
#68 | 2007-07-12Optimized Fc variants and methods for their generation
#69 | 2007-03-08Optimized Fc variants and methods for their generation
#70 | 2007-01-04Optimized Fc variants and methods for their generation
#71 | 2006-10-05Antibodies operably linked to selected chemoattractants
#72 | 2006-07-20Optimized Fc variants and methods for their generation
#73 | 2006-06-22IgG immunoglobulin variants with optimized effector function
#74 | 2006-06-08Optimized anti-CD20 monoclonal antibodies having Fc variants
#75 | 2006-02-02Optimized FC variants
#76 | 2005-03-10Optimized Fc variants
126844 ⎘